In caring for patients with chronic kidney disease, it is important to prevent and treat hyperphosphatemia with a combination of dietary restrictions and phosphorus binders. This post reviews the pathophysiology of hyperphosphatemia.
Cleveland Clinic researchers recently published a study showing that there is heterogeneity in the survival rates of renal cancer surgery patients who develop CKD primarily due to the removal of nephrons.
Anemia of renal disease is common and is associated with significant morbidity and death. But targeting normal hemoglobin levels can be harmful, and benefits of erythropoiesis-stimulating agents have been called into question. This overview helps nephrologists and PCPs sort things out.
African-Americans have a greater burden of chronic kidney disease than whites. They are more than three times as likely as whites to develop end-stage renal disease, even after adjusting for age, disease stage, smoking, medications and comorbidities. Why this is so has been the focus of much speculation and research. Are genetics at play?
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Minority Men’s Health Fair and Minority Men’s Health Center at Cleveland Clinic are “friendly portals of entry” to the healthcare system aimed at reducing disparities for underserved populations.
Why does kidney disease disproportionately affect minorities? What is the connection between renal disease, diabetes and hypertension? These are some of the issues Cleveland Clinic renal disease researchers are pursuing.
Instead of one in three U.S. adults having hypertension, nearly one in two will now be classified as having hypertension. Accurate measurements in and out of the office are key. Lifestyle changes are getting major emphasis.
Research shows that both high blood pressure and very low blood pressure can be dangerous for patients with chronic kidney disease.
A study of the associations between hemoglobin A1c (HbA1c) levels and end-stage renal disease and death in a population with diabetes and chronic kidney disease reveals important information, and guidance for physicians counseling their diabetic patients.
Diet modifications aimed at restoring and sustaining beneficial gut bacteria can improve clinical results in patients with chronic kidney disease, says Cleveland Clinic nephrologist Priya Kalahasti, MD. Reducing protein, increasing vegetables, adding probiotics and periodically fasting to rest the gut has improved patients’ lab test values such as serum creatinine and glomerular filtration rate.